× Home Projects Partners FAQs Contacts
ihi-logo

publications

On average IHI researchers publish 10 scientific articles each month and these amount on average to over 100 scientific articles annually.

Published on: Aug. 5, 2025

Stigma, depression and pillbox return among adults living with HIV in rural Tanzania: A prospective cohort study

Ndege, R., Okuma, J., Kivuma, B., Magnolini, R., Samson, L., Luoga, E., Senkoro, E., Kitau, O., Vanobberghen, F., Paris, D. H., Weisser, M., & KIULARCO Study Group

HIV Medicine

Read article
Published on: Aug. 2, 2025

From warehouse to ward: applying implementation research methods to the device identification, qualification, distribution, and management process within the Newborn Essential Solutions and Technologies (NEST360) alliance

Dougherty, K., Kirby, R. P., Claud, K., Palamountain, K. M., Asma, E., Alooh, M., Kumara, D., Gate, V., Khalid, A., Banda, G., Peter, H. D., Osuagwu, C., Richards-Kortum, R., Oden, Z. M., Bohne, C. A., & Hirschhorn, L. R.

BMC Global Public Health

Read article
Published on: July 31, 2025

Safeguarding malaria control gains in Africa through 'species sanitation' and structural resilience

Okumu F, Odero JO, Charlwood JD, Knols BGJ, Monroe A.

Trends in Parasitology

Read article
Published on: July 16, 2025

Antibody responses to SG6, AgSAP, and SAMSP1 following Anopheline salivary exposure

Williams, R. J., Swinehart, B. D., Abouneameh, S., Rutha, I. J., Msolo, D. C., Tarimo, B., Fikrig, E., Mathias, D., Ngasala, B., Chuang, Y. M., & Lin, J. T.

medRxiv

Read article
Published on: July 16, 2025

A comparison of the costs and patterns of expenditure for care for severe mental illness in five countries with different levels of economic development

Park AL, Jez O, Kilian R, Charles A, Kalha J, Korde P, Lachmann M, Mahlke C, Moran G, Nakku J, Ngakongwa F, Niwemuhwezi J, Nixdorf R, Ryan G, Shamba D, Slade M, Waldmann T.

Epidemiology and Psychiatric Sciences

Read article
Published on: July 10, 2025

Hypertensive disorders of pregnancy and perinatal outcomes: two prospective cohort studies of nulliparous women in India and Tanzania

Pembe AB, Dwarkanath P, Kikula A, Raj JM, Perumal N, Paulo HA, M R, Duggan CP, Masanja HM, Chopra N, Sando MM, Thomas T, Yelverton CA, Muhihi A, Kurpad AV, Fawzi WW, Wylie BJ, Sudfeld CR.

BMJ Global Health

Read article
Published on: July 8, 2025

Delpazolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-DECODE-01): a prospective, randomised, open-label, phase 2b, dose-finding trial

Minja LT, van der Feltz I, Manyama C, Mpagama S, Mhimbira F, Noreña I, Sebe M, Rassool M, Wallis RS, Ntinginya N, Liyoyo A, Mbeya B, Wagnerberger L, Zumba T, Peter DD, Makkan H, Sloan DJ, Brake LT, Schildkraut JA, Aarnoutse R, McHugh TD, Wildner L, Boeree MJ, Geiter L, Cho YL, Aldana BH, Phillips PPJ, Hoelscher M, Svensson EM, Heinrich N; PanACEA consortium.

The Lancet Infectious Diseases

Read article
Published on: July 8, 2025

Sutezolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-SUDOCU-01): a prospective, open-label, randomised, phase 2b dose-finding trial

Heinrich N, Manyama C, Koele SE, Mpagama S, Mhimbira F, Sebe M, Wallis RS, Ntinginya N, Liyoyo A, Huglin B, Minja LT, Wagnerberger L, Stoycheva K, Zumba T, Noreña I, Peter DD, Makkan H, Sloan DJ, Brake LT, Schildkraut J, Aarnoutse RE, McHugh TD, Wildner L, Boeree M, Aldana BH, Phillips PPJ, Hoelscher M, Svensson EM; PanACEA consortium.

The Lancet Infectious Diseases

Read article
Published on: July 7, 2025

Genomic evidence of spatially structured gene flow and divergent insecticide resistance backgrounds of the malaria vector Anopheles funestus in Tanzania

Odero JO, Nambunga IH, Bwanary H, Mkandawile G, Paliga JM, Mapua SA, Mwinyi SH, Ngowo HS, Govella NJ, Kaindoa EW, Tripet F, Hernandez-Koutoucheva A, Ferguson HM, Clarkson CS, Miles A, Weetman D, Baldini F, Okumu FO, Dennis TPW.

Genetics

Read article
Published on: July 4, 2025

Cardiac safety of bedaquiline, delamanid and moxifloxacin co-administered with or without varying doses of sutezolid or delpazolid for the treatment of drug-susceptible TB

Koele SE, Stoycheva K, Mtweve C, Manyama C, Mpagama S, Mhimbira F, Wallis R, Ntinginya NE, Liyoyo A, Huglin B, Minja LT, Wagnerberger L, Zumba T, Noreña I, Peter DD, Beattie T, Makkan H, Sloan DJ, Te Brake L, Aarnoutse RE, McHugh TD, Wildner L, Schildkraut J, Aldana BH, Phillips PPJ, Hoelscher M, Svensson EM, Heinrich N; PanACEA consortium.

The Journal of Antimicrobial Chemotherapy

Read article